Fluoxetine-induced Raynaud's phenomenon.
Rudnick
A
A
Brull Tel-Aviv Community Mental Health Center, Tel Aviv University Sackler Medical School, Israel.
Modai
I
I
Zelikovski
A
A
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010991:Plethysmography; D011928:Raynaud Disease / Q000139:chemically induced* / Q000503:physiopathology
D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine